PMC:7212965 / 1666-1990 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":30,"end":35},"obj":"Body_part"},{"id":"T6","span":{"begin":122,"end":129},"obj":"Body_part"},{"id":"T7","span":{"begin":293,"end":298},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma82749"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T5","span":{"begin":30,"end":35},"obj":"Body_part"},{"id":"T6","span":{"begin":293,"end":298},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":262,"end":270},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":30,"end":35},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T16","span":{"begin":30,"end":35},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T17","span":{"begin":293,"end":298},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T18","span":{"begin":293,"end":298},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":67,"end":76},"obj":"Chemical"},{"id":"T7","span":{"begin":122,"end":129},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_132943"},{"id":"A5","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_29995"},{"id":"A6","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_72314"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_16449"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":30,"end":49},"obj":"Phenotype"},{"id":"T11","span":{"begin":262,"end":270},"obj":"Phenotype"},{"id":"T12","span":{"begin":272,"end":287},"obj":"Phenotype"},{"id":"T13","span":{"begin":293,"end":312},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001392"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0002017"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0001392"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}

{"project":"LitCovid-PubTator","denotations":[{"id":"61","span":{"begin":21,"end":49},"obj":"Disease"},{"id":"62","span":{"begin":262,"end":270},"obj":"Disease"},{"id":"63","span":{"begin":272,"end":278},"obj":"Disease"},{"id":"64","span":{"begin":279,"end":287},"obj":"Disease"},{"id":"65","span":{"begin":293,"end":312},"obj":"Disease"}],"attributes":[{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D006973"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D003967"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D009325"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D014839"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D008107"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"valence estimates of elevated liver abnormalities were as follows: aspartate transaminase 15.0% (95% CI, 13.6%–16.5%) and alanine transaminase 15.0% (95% CI, 13.6%–16.4%). When we compared studies from China to studies from other countries in subgroup analyses, diarrhea, nausea/vomiting, and liver abnormalities were more p"}